The Union Cycliste Internationale (UCI) announces that the UCI Anti-Doping Tribunal has rendered a decision against French rider Franck Bonnamour.
The Tribunal found that Franck Bonnamour had committed an Anti-Doping Rule Violation (ADRV) for use of a prohibited substance or a prohibited method due to an unexplained abnormality in his Athlete Biological Passport (*) in 2022. As a consequence, the Tribunal has imposed a four-year period of ineligibility on the rider.
The period of ineligibility started on 5 February 2024 and will remain in force until 4 February 2028 in accordance with the World Anti-Doping Code and the UCI Anti-Doping Rules.
Furthermore, in line with the Procedural Rules of the Anti-Doping Tribunal, the decision will be published on the UCI website. The decision may be appealed before the Court of Arbitration for Sport (CAS) within one month.
The UCI will not comment further on the matter.
(*) The Athlete Biological Passport (ABP) is an individual electronic record for each rider, in which the results of all doping tests collected as part of the ABP programme over a given period are collated. The International Testing Agency (ITA), the independent entity to which the UCI delegated its anti-doping programme while retaining responsibility for the management of results and the prosecution of anti-doping rule violations, manages the ABP programme in collaboration with the Athlete Passport Management Unit (APMU) of Lausanne, Switzerland (the APMU of Lausanne is associated with the World Anti-Doping Agency accredited Laboratory of Lausanne). Athlete Biological cases are prosecuted based on the opinion of an independent Expert Panel of the APMU.